Hospital mergers arrive with a consistent pitch: duplicated services eliminated, capital invested, quality improved. The empirical record on the central claim — what happens to prices — is unusually one-sided. The health economics literature, synthesized across decades by researchers including Martin Gaynor, Kate Ho and Robert Town in the National Bureau of Economic Research's review work, finds that hospital mergers in concentrated markets raise prices substantially, with classic studies of California and other markets finding price increases in the range of 20 to 40 percent after rival combinations, and cross-market mergers — where the acquirer has no geographic overlap — adding smaller but measurable increases of roughly 5 to 10 percent.
This article publishes information, not medical or insurance advice. For consumers, the practical consequence is structural: market concentration shapes premiums and hospital prices regardless of any individual's choices, though the transparency tools and network checks described below operate at the personal level.
Why merging raises prices
Hospitals do not set prices in a market the way retailers do; they negotiate with insurers, and leverage decides outcomes. A merger removes the alternative an insurer could threaten to steer patients toward, which raises the merged system's negotiating position even for patients who never use the acquired hospital. Kate Ho's research on negotiated contracts showed insurers sometimes agree to include entire systems they would not otherwise choose, precisely because the system's threatened exclusion would cost them subscribers. Economists call this the bargaining-power channel, and it works even when the merged hospitals promise regulators no price increases — prices move through contracts, not rate sheets.
What the merger wave looks like
The American Hospital Association's trend data show the shape: the count of US community hospitals fell from roughly 6,700 in the mid-1990s to under 6,000 by the 2020s, while the share of hospitals in systems grew. The 2010s saw a sustained merger surge — well over 100 deals in peak years, per analysis of American Hospital Association annual survey data by researchers at Rice University and other institutions — and consolidation continued through the 2020s, accelerated by post-pandemic financial strain on rural and safety-net hospitals. Two features define the recent wave: cross-market deals, where systems acquire hospitals in distant regions to build negotiating scale against national insurers, and vertical deals, where systems acquire physician practices, which the American Medical Association's benchmark surveys show shifted a growing share of physicians into hospital employment, raising prices for the same office visits, per studies published in Health Affairs finding roughly 10 to 15 percent higher commercial prices after practice acquisitions.
Does quality improve to offset price?
The deal pitch rests on quality synergies, and the evidence is mixed at best. Early work found small quality gains in some merging pairs; the larger subsequent literature, including research by Cooper and colleagues and several Health Affairs syntheses, finds no consistent quality improvement from rival mergers and some evidence of worsening in highly concentrated markets. Rural acquisitions are the genuine exception that merger defenders cite accurately: for a failing rural hospital, absorption by a regional system can preserve access that closure would end — closures hit rural communities hard, and a merged rural hospital that survives is better than no hospital. The economics distinguish access-preservation mergers from leverage mergers, even when deal documents blur them.
Related stories: Hospital Price Transparency Rules: What Hospitals Must Publish and How to Use It · How to Read an Itemized Hospital Bill — and Catch the Errors Before They Become Yours.
What regulators have done — and can do
The Federal Trade Commission and state attorneys general have challenged hospital mergers since the 1980s, but historical litigated wins were rare, and the agencies increasingly shifted to retrospective studies and structural presumptions. The tool kit has grown: states now require merger notice, and the FTC's 2023–2024 premerger notification rule overhaul expanded the information agencies see before deals close. The most active legal frontier is vertical consolidation — physician practice acquisitions — where several state laws and FTC enforcement actions since 2023 have targeted hospital purchase of independent practices. Consumer advocacy groups, including the American Hospital Patients' coalition ecosystem and researchers publishing in Health Affairs, document that most hospital mergers still close without challenge because review thresholds capture only large deals.
How this reaches your premium
The chain from merger to household budget runs through insurance renewal. When a dominant system raises negotiated rates, employers with self-funded plans absorb them first and adjust employee contributions; fully insured plans adjust premiums at renewal. Health economist analyses of premium consequences estimate that concentrated hospital markets raise employer premium growth measurably, with some studies attributing several percentage points of annual premium growth to hospital consolidation effects. The geographic irony: a market with one dominant system often shows higher prices with no visible quality difference from competing metros, which is exactly what price transparency data now lets employers and researchers confirm. Some of the strongest pressure against consolidation now comes from large self-insured employers who can see the rate trajectory in their own claims data and lobby regulators accordingly.
Public hospitals and nonprofit systems complicate the narrative in one direction: consolidation among nonprofits dominates the statistics, since most US hospitals are nonprofit, and nonprofit status does not exempt a system from the bargaining analysis — negotiated prices for nonprofit systems rose with concentration just as for-profits' did, per the same literature. The tax-exemption questions raised elsewhere on this site intersect here: a system gaining monopoly pricing power while holding nonprofit status faces both antitrust and community-benefit scrutiny, from different agencies with different tools.
What can a patient actually do?
Concentration is a market-level problem, but three personal responses exist. During open enrollment, compare plans partly on which hospitals they include — premium differences often reflect exactly the leverage wars described here, and a plan anchored to a competing system can price lower. For scheduled care, use the price transparency data hospitals must publish and get good-faith estimates; within a merged system, identical services can price differently across its campuses. And watch deal news in your market: when a merger is announced, insurance rates in following renewal cycles are where it lands. Support for stronger state merger review, if you track policy, is the lever that operates upstream.
For more context, read Hospital Price Transparency Rules: What Hospitals Must Publish and How to Use It.
For more context, read nonprofit hospitals.
For more context, read hospital charity care.